Daniel R. Frisch

ORCID: 0000-0002-7645-6405
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac Arrhythmias and Treatments
  • Atrial Fibrillation Management and Outcomes
  • Cardiac pacing and defibrillation studies
  • Cardiac electrophysiology and arrhythmias
  • ECG Monitoring and Analysis
  • Cardiovascular Syncope and Autonomic Disorders
  • Cardiac Imaging and Diagnostics
  • Acute Myocardial Infarction Research
  • Coronary Interventions and Diagnostics
  • Cardiovascular Effects of Exercise
  • Venous Thromboembolism Diagnosis and Management
  • Target Tracking and Data Fusion in Sensor Networks
  • Cardiac Structural Anomalies and Repair
  • Human-Automation Interaction and Safety
  • Amyloidosis: Diagnosis, Treatment, Outcomes
  • Heart Rate Variability and Autonomic Control
  • Bayesian Methods and Mixture Models
  • Neurological disorders and treatments
  • Cardiovascular and exercise physiology
  • Healthcare Technology and Patient Monitoring
  • Fiscal Policy and Economic Growth
  • Cardiovascular Function and Risk Factors
  • Health Systems, Economic Evaluations, Quality of Life
  • Vascular anomalies and interventions
  • Transplantation: Methods and Outcomes

Thomas Jefferson University Hospital
2013-2024

Karlsruhe Institute of Technology
2023-2024

Thomas Jefferson University
2010-2024

Johnson University
2024

Rutgers, The State University of New Jersey
2024

Mayo Clinic in Arizona
2024

Dow University of Health Sciences
2023

Jefferson University Hospitals
2022-2023

Scripps Clinic
2022

Lankenau Heart Institute
2019-2020

Background: Prior studies of cardiac rhythm management devices (pacemakers [PM] and implantable cardioverter defibrillators [ICD]) utilization in the United States have been limited to Medicare population. We evaluated national trends for implantation PMs ICDs including burden device replacement. Methods: The Nationwide Inpatient Sample was queried identify PM ICD patients between 1993 2006 using ICD-9-CM codes, demographics, health profile, economic data. Charlson Comorbidity Index (CCI)...

10.1111/j.1540-8159.2009.02670.x article EN Pacing and Clinical Electrophysiology 2010-01-04

Diagnosing atypical atrioventricular node-dependent long RP supraventricular tachycardias (SVTs) can be challenging.Nineteen patients with 20 SVTs (atypical nodal reentrant tachycardia without [n=11]/with [n=3] a bystander nodofascicular [NF] accessory pathway, orthodromic reciprocating [ORT] using decremental [permanent form of junctional tachycardia; n=4] or NF [NF n=2]) pathway underwent electrophysiological study. Postpacing interval (PPI)-tachycardia cycle length (TCL), corrected PPI,...

10.1161/circep.113.000187 article EN Circulation Arrhythmia and Electrophysiology 2013-04-30

Atrial fibrillation (AF) in patients with cardiac amyloidosis (CA) has been linked a worse prognosis. The current study aimed to determine the outcomes of AF catheter ablation CA.

10.1093/ehjopen/oead026 article EN cc-by-nc European Heart Journal Open 2023-03-01

Abstract Introduction High‐power short‐duration (HPSD) ablation is a novel strategy using contact force‐sensing catheters optimized for power‐controlled radiofrequency atrial fibrillation (AF). This study investigates the outcomes of HPSD (50 W delivered up to 15 s, Lesion Size Index 5–6) compared standard‐power standard‐duration (SPSD) (20–25 until 400–500 gram seconds, 60 s) and temperature‐controlled noncontact (TCNC) (20‐40 s ablation) settings. Methods We studied consecutive cases...

10.1111/jce.14868 article EN Journal of Cardiovascular Electrophysiology 2021-01-13

Mobile electrocardiograms (ECGs) (mECGs) using smartphone applications are an emerging technology.In the coronavirus disease 2019 (COVID-19) era, minimizing patient contact has gained increasing importance.Additionally, increased QT/corrected QT (QTc) monitoring concurrently been required.The KardiaMobile 6L ECG device, cleared by United States Food and Drug Administration (FDA) for recording ECGs, along with KardiaStation tablet application is a platform (AliveCor, Mountain View, CA, USA)...

10.19102/icrm.2021.120301 article EN Journal of Innovations in Cardiac Rhythm Management 2021-03-01

Atrial fibrillation (AF) is highly prevalent among cancer patients. The role of traditional risk stratification scores in the context different types these patients remains unknown. purpose this study was to determine discriminative accuracy CHA2DS2VASc score for ischemic stroke using receiver operating characteristic and area under curve. National Readmission Database (2015-2019) used identify all AF stratified by diagnosis, type, category (low; moderate; high risk). Outcomes at 30-day...

10.1016/j.jacadv.2023.100609 article EN cc-by JACC Advances 2023-09-16

Abstract Objective This study evaluated the risk of subclinical atrial fibrillation (AF) in patients with central retinal artery occlusion (CRAO) compared to those cryptogenic stroke using implantable loop recorders (ILR). Methods We conducted a retrospective analysis 273 consecutive who had ILRs inserted at our institution for either (n = 227) or CRAO 46). Our primary endpoint was time event new diagnosis AF by ILR. Univariable and multivariable Cox proportional hazard models were used...

10.1111/pace.13990 article EN Pacing and Clinical Electrophysiology 2020-06-22

10.19102/icrm.2021.120102s article EN Journal of Innovations in Cardiac Rhythm Management 2020-01-01

Abstract Background Mobile electrocardiograms (mECGs) utilizing smartphone applications are an emerging technology. Typically, a Lead I rhythm strip is recorded. However, interpretation can be difficult in patients with sinus and low amplitude P‐waves (SR‐LAP) or atrial flutter (AFL). We hypothesized that could independently obtain multi‐lead tracings using commercial mECG device, cardiologists who interpreted the would make more accurate diagnoses have confidence their compared to single...

10.1111/pace.13775 article EN Pacing and Clinical Electrophysiology 2019-08-10
Coming Soon ...